NO-independent mechanism mediates tempol-induced renal vasodilation in SHR

American Journal of Physiology - Renal Physiology

Volumn 289, Issue 6 58-6, 2005, Pages

  De Richelieu, Louise Tilma ^a   Sorensen, Charlotte Mehlin ^a   Holstein Rathlou, Niels Henrik ^a   Salomonsson, Max ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Angiotensin II; Hypertension; Nitric oxide; Oxidative stress; Renal hemodynamics; Spontaneously hypertensive rats

Indexed keywords

ANGIOTENSIN; DRINKING WATER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SUPEROXIDE DISMUTASE; TEMPOL;

ANIMAL EXPERIMENT; ARTERY CATHETER; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; KIDNEY ARTERY; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RAT STRAIN; RENAL ARTERY; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION; VASODILATATION;

EID: 27944461884     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00116.2005     Document Type: Article

References (54)

1. Adler S and Huang H. Impaired regulation of renal oxygen consumption in spontaneously hypertensive rats. J Am Soc Nephrol 13: 1788-1794, 2002.
2. Auch-Schwelk W, Katusic ZS, and Vanhoutte PM. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension 13: 859-864, 1989.
3. Beckman JS, Beckman TW, Chen J, Marshall PA, and Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624, 1990.
4. Campese VM, Ye S, Zhong H, Yanamadala V, Ye Z, and Chiu J. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am J Physiol Heart Circ Physiol 287: H695-H703, 2004.
5. 2 on afferent arteriolar diameter in normal rat kidney (Abstract). FASEB J 19: 2005.
6. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, and Wilcox CS. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39: 269-274, 2002.
7. Chatziantoniou C and Arendshorst WJ. Angiotensin and thromboxane in genetically hypertensive rats: renal blood flow and receptor studies. Am J Physiol Renal Fluid Electrolyte Physiol 261: F238-F247, 1991.
8. Chatziantoniou C, Daniels FH, and Arendshorst WJ. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 259: F372-F382, 1990.
9. Chen YF, Li PL, and Zou AP. Oxidative stress enhances the production and actions of adenosine in the kidney. Am J Physiol Regul Integr Comp Physiol 281: R1808-R1816, 2001.
10. Christensen S, Shalmi M, Hansen AK, and Marcussen N. Effects of perindopril and hydrochlorothiazide on the long-term progression of lithium-induced chronic renal failure in rats. Pharmacol Toxicol 80: 132-141, 1997.
11. DiBona GF and Kopp UC. Neural control of renal function. Physiol Rev 77: 75-197, 1997.
12. DiBona GF and Sawin LL. Effect of renal denervation on dynamic autoregulation of renal blood flow. Am J Physiol Renal Physiol 286: F1209-F1218, 2004.
13. Dobrian AD, Schriver SD, and Prewitt RL. Role of angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension. Hypertension 38: 361-366, 2001.
14. Feng JJ and Arendshorst WJ. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors. Am J Physiol Renal Fluid Electrolyte Physiol 271: F304-F313, 1996.
15. Feng JJ and Arendshorst WJ. Calcium signaling mechanisms in renal vascular responses to vasopressin in genetic hypertension. Hypertension 30: 1223-1231, 1997.
16. Galley HF, Thornton J, Howdle PD, Walker BE, and Webster NR. Combination oral antioxidant supplementation reduces blood pressure. Clin Sci (Lond) 92: 361-365, 1997.
17. Gao YJ and Lee RM. Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A(2) production. Br J Pharmacol 134: 1639-1646, 2001.
18. Gryglewski RJ, Palmer RM, and Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320: 454-456, 1986.
19. Hansen PB, Castrop H, Briggs J, and Schnermann J. Adenosine induces vasoconstriction through Gi-dependent activation of phospholipase C in isolated perfused afferent arterioles of mice. J Am Soc Nephrol 14: 2457-2465, 2003.
20. Ichihara A, Hayashi M, Hirota N, and Saruta T. Superoxide inhibits neuronal nitric oxide synthase influences on afferent arterioles in spontaneously hypertensive rats. Hypertension 37: 630-634, 2001.
21. Kagiyama S, Tsuchihashi T, Abe I, Matsumura K, and Fujishima M. Central infusion of L-arginine or superoxide dismutase does not alter arterial pressure in SHR. Hypertens Res 23: 339-343, 2000.
22. Kawada N, Imai E, Karber A, Welch WJ, and Wilcox CS. A mouse model of angiotensin II slow pressor response: role of oxidative stress. J Am Soc Nephrol 13: 2860-2868, 2002.
23. Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, and Hamilton CA. Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension 33: 1353-1358, 1999.
24. Kett MM, Bergstrom G, Alcorn D, Bertram JF, and Anderson WP. Renal vascular resistance properties and glomerular protection in early established SHR hypertension. J Hypertens 19: 1505-1512, 2001.
25. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, and Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 109: 2357-2362, 2004.
26. Kost CK Jr, Herzer WA, Li P, and Jackson EK. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats. J Pharmacol Exp Ther 269: 82-88, 1994.
27. Lopez B, Salom MG, Arregui B, Valero F, and Fenoy FJ. Role of superoxide in modulating the renal effects of angiotensin II. Hypertension 42: 1150-1156, 2003.
28. Ma YH, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BS, Harder DR, and Roman RJ. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 72: 126-136, 1993.
29. Majid DS and Nishiyama A. Nitric oxide blockade enhances renal responses to superoxide dismutase inhibition in dogs. Hypertension 39: 293-297, 2002.
30. Meng S, Cason GW, Gannon AW, Racusen LC, and Manning RD Jr. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 41: 1346-1352, 2003.
31. Nishiyama A, Fukui T, Fujisawa Y, Rahman M, Tian RX, Kimura S, and Abe Y. Systemic and regional hemodynamic responses to tempol in angiotensin II-infused hypertensive rats. Hypertension 37: 77-83, 2001.
32. Park JB, Touyz RM, Chen X, and Schiffrin EL. Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am J Hypertens 15: 78-84, 2002.
33. Racasan S, Joles JA, Boer P, Koomans HA, and Braam B. NO dependency of RBF and autoregulation in the spontaneously hypertensive rat. Am J Physiol Renal Physiol 285: F105-F112, 2003.
34. Rao GN, Runge MS, and Alexander RW. Hydrogen peroxide activation of cytosolic phospholipase A2 in vascular smooth muscle cells. Biochim Biophys Acta 1265: 67-72, 1995.
35. Rettig R. Does the kidney play a role in the aetiology of primary hypertension? Evidence from renal transplantation studies in rats and humans. J Hum Hypertens 7: 177-180, 1993.
36. Rettig R, Schmitt B, Pelzl B, and Speck T. The kidney and primary hypertension: contributions from renal transplantation studies in animals and humans. J Hypertens 11: 883-891, 1993.
37. Rodriguez-Puyol M, Griera-Merino M, Perez-Rivero G, Diez-Marques ML, Ruiz-Torres MP, and Rodriguez-Puyol D. Angiotensin II induces a rapid and transient increase of reactive oxygen species. Antioxid Redox Signal 4: 869-875, 2002.
38. Rubanyi GM and Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol Heart Circ Physiol 250: H822-H827, 1986.
39. Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, and Corrocher R. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 16: 1267-1271, 1998.
40. Sagar S, Kallo IJ, Kaul N, Ganguly NK, and Sharma BK. Oxygen free radicals in essential hypertension. Mol Cell Biochem 111: 103-108, 1992.
41. Salomonsson M and Arendshorst WJ. Calcium recruitment in renal vasculature: NE effects on blood flow and cytosolic calcium concentration. Am J Physiol Renal Physiol 276: F700-F710, 1999.
42. Schnackenberg CG, Welch WJ, and Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32: 59-64, 1998.
43. Schnackenberg CG and Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2α Hypertension 33: 424-428, 1999.
44. Schoonmaker GC, Fallet RW, and Carmines PK. Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus. Am J Physiol Renal Physiol 278: F302-F309, 2000.
45. Shastri S, Gopalakrishnan V, Poduri R, and Di Wang H. Tempol selectively attenuates angiotensin II evoked vasoconstrictor responses in spontaneously hypertensive rats. J Hypertens 20: 1381-1391, 2002.
46. Shokoji T, Fujisawa Y, Kimura S, Rahman M, Kiyomoto H, Matsubara K, Moriwaki K, Aki Y, Miyatake A, Kohno M, Abe Y, and Nishiyama A. Effects of local administrations of tempol and diethyldithio-carbamic on peripheral nerve activity. Hypertension 44: 236-243, 2004.
47. Shokoji T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura S, Kohno M, and Abe Y. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 41: 266-273, 2003.
48. Steendahl J, Holstein-Rathlou NH, Sorensen CM, and Salomonsson M. Effects of chloride channel blockers on rat renal vascular responses to angiotensin II and norepinephrine. Am J Physiol Renal Physiol 286: F323-F330, 2004.
49. Suzuki H, Swei A, Zweifach BW, and Schmid-Schonbein GW. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography. Hypertension 25: 1083-1089, 1995.
50. Vyas SJ and Jackson EK. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats. J Pharmacol Exp Ther 273: 768-777, 1995.
51. Wilcox CS. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol Scand 179: 217-223, 2003.
52. Xu H, Fink GD, and Galligan JJ. Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats, Am J Physiol Heart Circ Physiol 283: H885-H892, 2002.
53. - in DOCA-salt rats. Hypertension 43: 329-334, 2004.
54. Yanes L, Romero D, Iliescu R, Cucchiarelli VE, Fortepiani LA, Santacruz F, Bell W, Zhang H, and Reckelhoff JF. Systemic arterial pressure response to 2-week tempol therapy in SHR: involvement of NO, the RAS and oxidative stress. Am J Physiol Regul Integr Comp Physiol 288: R903-R908, 2005.